
| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| AL(L) | 767 | 81.0% | -4.37 | 37 | 12.9% |
| SLP(L) | 77 | 8.1% | 0.36 | 99 | 34.5% |
| LH(L) | 61 | 6.4% | 0.07 | 64 | 22.3% |
| SCL(L) | 20 | 2.1% | 1.20 | 46 | 16.0% |
| SIP(L) | 11 | 1.2% | 1.18 | 25 | 8.7% |
| PLP(L) | 8 | 0.8% | 0.91 | 15 | 5.2% |
| CentralBrain-unspecified | 3 | 0.3% | -1.58 | 1 | 0.3% |
| upstream partner | # | NT | conns M_vPNml51 | % In | CV |
|---|---|---|---|---|---|
| ORN_VA2 | 26 | ACh | 63 | 7.3% | 0.6 |
| LHPV10b1 (L) | 1 | ACh | 49 | 5.7% | 0.0 |
| lLN2T_c (L) | 2 | ACh | 42 | 4.9% | 0.2 |
| ALBN1 (R) | 1 | unc | 41 | 4.8% | 0.0 |
| VA3_adPN (L) | 2 | ACh | 40 | 4.6% | 0.1 |
| DL2v_adPN (L) | 4 | ACh | 38 | 4.4% | 0.5 |
| ALIN5 (R) | 1 | GABA | 34 | 3.9% | 0.0 |
| DL2d_adPN (L) | 5 | ACh | 27 | 3.1% | 0.8 |
| M_adPNm8 (L) | 3 | ACh | 26 | 3.0% | 0.6 |
| ORN_DP1m | 11 | ACh | 26 | 3.0% | 0.9 |
| VA2_adPN (L) | 1 | ACh | 24 | 2.8% | 0.0 |
| v2LN3A1_b (L) | 5 | ACh | 23 | 2.7% | 0.5 |
| ORN_DP1l | 11 | ACh | 21 | 2.4% | 0.8 |
| lLN1_bc (L) | 10 | ACh | 19 | 2.2% | 0.5 |
| VL2p_adPN (L) | 1 | ACh | 18 | 2.1% | 0.0 |
| lLN2P_a (L) | 3 | GABA | 16 | 1.9% | 0.8 |
| VC3_adPN (L) | 3 | ACh | 13 | 1.5% | 0.6 |
| lLN2X12 (L) | 6 | ACh | 13 | 1.5% | 0.7 |
| DP1l_adPN (L) | 1 | ACh | 12 | 1.4% | 0.0 |
| LHPV5a1 (L) | 4 | ACh | 12 | 1.4% | 0.3 |
| VL1_ilPN (L) | 1 | ACh | 11 | 1.3% | 0.0 |
| VA4_lPN (L) | 1 | ACh | 10 | 1.2% | 0.0 |
| M_lvPNm24 (L) | 2 | ACh | 10 | 1.2% | 0.2 |
| lLN2P_b (L) | 4 | GABA | 10 | 1.2% | 0.6 |
| ORN_DL2v | 5 | ACh | 10 | 1.2% | 0.3 |
| DM5_lPN (L) | 3 | ACh | 9 | 1.0% | 0.7 |
| v2LN39a (L) | 1 | Glu | 8 | 0.9% | 0.0 |
| LHAD1f5 (L) | 2 | ACh | 8 | 0.9% | 0.5 |
| lLN2P_c (L) | 2 | GABA | 8 | 0.9% | 0.2 |
| ORN_DL2d | 5 | ACh | 8 | 0.9% | 0.3 |
| PPL202 (L) | 1 | DA | 6 | 0.7% | 0.0 |
| v2LN3A (L) | 2 | unc | 6 | 0.7% | 0.7 |
| LHPV2a1_c (L) | 2 | GABA | 6 | 0.7% | 0.7 |
| lLN2T_e (L) | 2 | ACh | 6 | 0.7% | 0.7 |
| ORN_VL2p | 4 | ACh | 6 | 0.7% | 0.6 |
| v2LNX01 (L) | 1 | unc | 5 | 0.6% | 0.0 |
| OA-VUMa5 (M) | 1 | OA | 5 | 0.6% | 0.0 |
| M_l2PNl20 (L) | 1 | ACh | 5 | 0.6% | 0.0 |
| DP1m_adPN (L) | 1 | ACh | 5 | 0.6% | 0.0 |
| lLN2X04 (L) | 2 | ACh | 5 | 0.6% | 0.6 |
| lLN2T_d (L) | 2 | unc | 5 | 0.6% | 0.2 |
| ORN_VA3 | 4 | ACh | 5 | 0.6% | 0.3 |
| VA7l_adPN (L) | 1 | ACh | 4 | 0.5% | 0.0 |
| LHPD2a6 (L) | 1 | Glu | 4 | 0.5% | 0.0 |
| M_adPNm7 (L) | 1 | ACh | 4 | 0.5% | 0.0 |
| M_lvPNm25 (L) | 1 | ACh | 4 | 0.5% | 0.0 |
| LHPV4m1 (L) | 1 | ACh | 4 | 0.5% | 0.0 |
| M_l2PNl21 (L) | 1 | ACh | 4 | 0.5% | 0.0 |
| v2LN30 (L) | 1 | unc | 4 | 0.5% | 0.0 |
| AL-MBDL1 (L) | 1 | ACh | 4 | 0.5% | 0.0 |
| VA1v_vPN (L) | 2 | GABA | 4 | 0.5% | 0.5 |
| VM3_adPN (L) | 2 | ACh | 4 | 0.5% | 0.5 |
| LHPV2a1_a (L) | 1 | GABA | 3 | 0.3% | 0.0 |
| ORN_VC3 | 1 | ACh | 3 | 0.3% | 0.0 |
| LHPV5g1_b (L) | 1 | ACh | 3 | 0.3% | 0.0 |
| M_lPNm11D (L) | 1 | ACh | 3 | 0.3% | 0.0 |
| v2LN3A1_a (R) | 1 | ACh | 3 | 0.3% | 0.0 |
| SIP071 (L) | 1 | ACh | 3 | 0.3% | 0.0 |
| M_vPNml50 (L) | 1 | GABA | 3 | 0.3% | 0.0 |
| ALIN1 (L) | 1 | unc | 3 | 0.3% | 0.0 |
| VL1_ilPN (R) | 1 | ACh | 3 | 0.3% | 0.0 |
| AL-MBDL1 (R) | 1 | ACh | 3 | 0.3% | 0.0 |
| LHPV3a1 (L) | 2 | ACh | 3 | 0.3% | 0.3 |
| M_adPNm5 (L) | 2 | ACh | 3 | 0.3% | 0.3 |
| CB3202 (L) | 2 | ACh | 3 | 0.3% | 0.3 |
| lLN12A (L) | 2 | ACh | 3 | 0.3% | 0.3 |
| vLN26 (L) | 1 | unc | 2 | 0.2% | 0.0 |
| CB1883 (R) | 1 | ACh | 2 | 0.2% | 0.0 |
| M_vPNml63 (L) | 1 | GABA | 2 | 0.2% | 0.0 |
| M_spPN4t9 (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| VC2_lPN (L) | 1 | ACh | 2 | 0.2% | 0.0 |
| ALIN1 (R) | 1 | unc | 2 | 0.2% | 0.0 |
| lLN2F_b (L) | 1 | GABA | 2 | 0.2% | 0.0 |
| lLN2T_a (L) | 2 | ACh | 2 | 0.2% | 0.0 |
| lLN2R_a (L) | 2 | GABA | 2 | 0.2% | 0.0 |
| VA1v_adPN (L) | 2 | ACh | 2 | 0.2% | 0.0 |
| lLN2T_b (L) | 2 | ACh | 2 | 0.2% | 0.0 |
| ORN_VA4 | 1 | ACh | 1 | 0.1% | 0.0 |
| CB2550 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| v2LN37 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| CB0683 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| lLN2X02 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| il3LN6 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| VL1_vPN (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| M_l2PNm15 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| SLP003 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| CB2845 (L) | 1 | unc | 1 | 0.1% | 0.0 |
| LHAV7a5 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| CB1699 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| LHPV5a2 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LHPD2a4_a (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| CB3417 (L) | 1 | unc | 1 | 0.1% | 0.0 |
| v2LN3A1_a (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LHAV2b4 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LH002m (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| Z_vPNml1 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| SIP052 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| M_lvPNm27 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LHPD5f1 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| LHPV2a1_d (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| SLP473 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| v2LN33 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LH005m (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| LHPD2d1 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| SMP143 (L) | 1 | unc | 1 | 0.1% | 0.0 |
| VC5_lvPN (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LHAV2b2_d (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LHPV2g1 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| LHPV10d1 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| DA1_vPN (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| lLN1_a (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| lLN2X11 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| VA5_lPN (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| SLP457 (L) | 1 | unc | 1 | 0.1% | 0.0 |
| OA-VUMa2 (M) | 1 | OA | 1 | 0.1% | 0.0 |
| lLN8 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| M_l2PNl20 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| CRE011 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| VL2a_adPN (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| lLN2F_a (L) | 1 | unc | 1 | 0.1% | 0.0 |
| downstream partner | # | NT | conns M_vPNml51 | % Out | CV |
|---|---|---|---|---|---|
| LHPD2c7 (L) | 2 | Glu | 36 | 9.9% | 0.3 |
| vLN25 (L) | 2 | Glu | 20 | 5.5% | 0.1 |
| SLP327 (L) | 1 | ACh | 17 | 4.7% | 0.0 |
| LHPD2d1 (L) | 1 | Glu | 16 | 4.4% | 0.0 |
| SIP003_a (L) | 1 | ACh | 11 | 3.0% | 0.0 |
| SIP042_b (L) | 2 | Glu | 11 | 3.0% | 0.3 |
| LHCENT10 (L) | 1 | GABA | 10 | 2.7% | 0.0 |
| VP1d+VP4_l2PN1 (L) | 1 | ACh | 10 | 2.7% | 0.0 |
| VA3_adPN (L) | 2 | ACh | 10 | 2.7% | 0.2 |
| AL-MBDL1 (L) | 1 | ACh | 9 | 2.5% | 0.0 |
| SIP042_a (L) | 3 | Glu | 8 | 2.2% | 0.2 |
| LHPD2a4_a (L) | 4 | ACh | 8 | 2.2% | 0.5 |
| MBON04 (L) | 1 | Glu | 6 | 1.6% | 0.0 |
| SIP052 (L) | 1 | Glu | 6 | 1.6% | 0.0 |
| LH005m (L) | 1 | GABA | 6 | 1.6% | 0.0 |
| SIP053 (L) | 2 | ACh | 6 | 1.6% | 0.3 |
| DL2v_adPN (L) | 3 | ACh | 6 | 1.6% | 0.4 |
| SIP022 (L) | 1 | ACh | 5 | 1.4% | 0.0 |
| PPL202 (L) | 1 | DA | 5 | 1.4% | 0.0 |
| AVLP209 (L) | 1 | GABA | 5 | 1.4% | 0.0 |
| SIP003_b (L) | 2 | ACh | 5 | 1.4% | 0.6 |
| LHAV4j1 (L) | 1 | GABA | 4 | 1.1% | 0.0 |
| SIP018 (L) | 1 | Glu | 4 | 1.1% | 0.0 |
| LHPV6g1 (L) | 1 | Glu | 4 | 1.1% | 0.0 |
| M_vPNml50 (L) | 1 | GABA | 4 | 1.1% | 0.0 |
| VL2p_adPN (L) | 1 | ACh | 4 | 1.1% | 0.0 |
| LT52 (L) | 3 | Glu | 4 | 1.1% | 0.4 |
| SIP029 (L) | 1 | ACh | 3 | 0.8% | 0.0 |
| SLP118 (L) | 1 | ACh | 3 | 0.8% | 0.0 |
| v2LN42 (L) | 1 | Glu | 3 | 0.8% | 0.0 |
| CB1883 (R) | 1 | ACh | 3 | 0.8% | 0.0 |
| LHPV3c1 (L) | 1 | ACh | 3 | 0.8% | 0.0 |
| VA4_lPN (L) | 1 | ACh | 3 | 0.8% | 0.0 |
| LHCENT3 (L) | 1 | GABA | 3 | 0.8% | 0.0 |
| VA2_adPN (L) | 1 | ACh | 3 | 0.8% | 0.0 |
| DP1l_adPN (L) | 1 | ACh | 3 | 0.8% | 0.0 |
| LHPD2c6 (L) | 2 | Glu | 3 | 0.8% | 0.3 |
| LHPD2a6 (L) | 2 | Glu | 3 | 0.8% | 0.3 |
| CB1308 (L) | 1 | ACh | 2 | 0.5% | 0.0 |
| LHPV2a1_a (L) | 1 | GABA | 2 | 0.5% | 0.0 |
| LHPV2c1_a (L) | 1 | GABA | 2 | 0.5% | 0.0 |
| CB2185 (L) | 1 | unc | 2 | 0.5% | 0.0 |
| CB2736 (L) | 1 | Glu | 2 | 0.5% | 0.0 |
| LHPD2a5_b (L) | 1 | Glu | 2 | 0.5% | 0.0 |
| LHPD2a4_b (L) | 1 | ACh | 2 | 0.5% | 0.0 |
| LHPV2a1_c (L) | 1 | GABA | 2 | 0.5% | 0.0 |
| LHPV5g1_b (L) | 1 | ACh | 2 | 0.5% | 0.0 |
| vLN28 (L) | 1 | Glu | 2 | 0.5% | 0.0 |
| CB4083 (L) | 1 | Glu | 2 | 0.5% | 0.0 |
| LHAV4a1_b (L) | 1 | GABA | 2 | 0.5% | 0.0 |
| LHPV4m1 (L) | 1 | ACh | 2 | 0.5% | 0.0 |
| PLP257 (L) | 1 | GABA | 2 | 0.5% | 0.0 |
| SMP108 (R) | 1 | ACh | 2 | 0.5% | 0.0 |
| CB1149 (L) | 2 | Glu | 2 | 0.5% | 0.0 |
| CB1699 (L) | 2 | Glu | 2 | 0.5% | 0.0 |
| CB2550 (L) | 2 | ACh | 2 | 0.5% | 0.0 |
| lLN1_bc (L) | 2 | ACh | 2 | 0.5% | 0.0 |
| CB1148 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| v2LN40_2 (L) | 1 | unc | 1 | 0.3% | 0.0 |
| DL2d_adPN (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| CB3147 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| LHPD2a2 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| CB0656 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| SMP457 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| WEDPN1A (L) | 1 | GABA | 1 | 0.3% | 0.0 |
| LHPD5d1 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| SIP088 (R) | 1 | ACh | 1 | 0.3% | 0.0 |
| SMP142 (L) | 1 | unc | 1 | 0.3% | 0.0 |
| ALON3 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| LHPV2a1_d (L) | 1 | GABA | 1 | 0.3% | 0.0 |
| LHPV3a1 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| SLP328 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| SIP066 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| CB2711 (L) | 1 | GABA | 1 | 0.3% | 0.0 |
| CB2262 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| LHPV5b3 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| CB1200 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| CB2194 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| LHPV5a1 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| SIP049 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| CB1457 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| CB4208 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| CB1527 (L) | 1 | GABA | 1 | 0.3% | 0.0 |
| M_lvPNm30 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| SIP015 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| LHPV2a2 (L) | 1 | GABA | 1 | 0.3% | 0.0 |
| LHPD2a1 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| LHPV3b1_b (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| lLN2P_a (L) | 1 | GABA | 1 | 0.3% | 0.0 |
| VL2a_vPN (L) | 1 | GABA | 1 | 0.3% | 0.0 |
| SLP098 (L) | 1 | Glu | 1 | 0.3% | 0.0 |
| VL2p_vPN (L) | 1 | GABA | 1 | 0.3% | 0.0 |
| M_lPNm13 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| VM4_lvPN (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| v2LN33 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| M_lvPNm25 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| VC5_lvPN (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| LHAV2b2_d (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| M_vPNml63 (L) | 1 | GABA | 1 | 0.3% | 0.0 |
| vLN24 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| AVLP035 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| LHAD2b1 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| LHAV3k1 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| ALIN5 (R) | 1 | GABA | 1 | 0.3% | 0.0 |
| v2LN30 (L) | 1 | unc | 1 | 0.3% | 0.0 |
| LHPD4c1 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| LoVP54 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| LHCENT11 (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| lLN2F_b (L) | 1 | GABA | 1 | 0.3% | 0.0 |
| VL2a_adPN (L) | 1 | ACh | 1 | 0.3% | 0.0 |
| SMP108 (L) | 1 | ACh | 1 | 0.3% | 0.0 |